Board of Directors
|
|
Karen Ballen, MD
Division Chief, Hematology and Oncology
University of Virginia School of Medicine
Charlottesville, Virginia
2021-2023
|
 |
Tomasz Baran, MD, MBA
Vice President
PBKM/FamiCord Group
Warsaw, Poland
2022-2024
|
 |
Peter Bawin, MBA
Global Vice President, Commercial Life Sciences
CooperSurgical
Los Angeles, California
2022-2025
|
 |
Jonathan Carmichael, PhD
Director Laboratory Services
Viacord
Hebron, Kentucky
2022-2023
|
|
|
Calvin Cole
Managing Partner
CTH BioSourcing
Austin, Texas
2016-2023
|
|
|
Colleen Delaney, MD, MSc (Vice President)
Founder and Chief Scientific Officer
Deverra Therapeutics
Seattle, Washington
2014-2025
|
 |
Ngaire Elwood, PhD
Director
BMDI Cord Blood Bank
Melbourne, Australia
2022-2025
|
|
|
Marcie Finney, MS, MBA (Treasurer)
Executive Director
Cleveland Cord Blood Center
Cleveland, Ohio
2020-2025
|
|
|
Joanne Kurtzberg, MD (President)
Director
Carolinas Cord Blood Bank
Durham, North Carolina
2014-2025
|
|
|
Charles Lu, MBA
Chief Commercial Officer
Mononuclear Therapeutics Ltd.
Hong Kong
2019-2024
|
 |
Caridad Martinez, MD
Chief, Pediatric Stem Cell Transplant and Cellular Therapies
Texas Children’s Hospital
Houston, Texas
2022-2025
|
|
|
Aby J. Mathew, PhD
Senior Vice President & Chief Technology Officer
BioLife Solutions, Inc.
Bothell, Washington
2014-2023
|
|
|
Filippo Milano, MD, PhD
Associate Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington
2021-2024
|
|
|
Beth H. Shaz, MD (Secretary)
Deputy Director
Marcus Center for Cellular Cures
Durham, North Carolina
2014-2023
|
|
|
Jonas C. Wang, PhD
Chairman and Chief Executive Officer
StemCyte
Baldwin Park, California
2020-2025
|
 |
Jeffrey Wilson
Assistant Director of Operations
MD Anderson Cord Blood Bank
Houston, Texas
2018-2024
|
 |
Robert Wynn, MB, BChir, MD, MRCP, FRCPath
Professor, Department of Pediatric BMT
Royal Manchester Children’s Hospital
Manchester, United Kingdom
2020-2025
|
| |
|
|
